Addressing Disparities in Dermatology

At the forefront of a groundbreaking discussion at the 2025 New Wave Dermatology Conference, Dr. Steven Daveluy, a prominent associate professor at Wayne State University, shed light on pressing issues in dermatological care. His talk, 'Color-Centric Care: Enhancing Dermatologic Treatments for All Skin Types', tackled the stark racial disparities that plague the field.

Dr. Daveluy revealed some startling findings from recent literature. For instance, Black patients suffering from psoriasis often face fewer options, particularly when it comes to biologic therapies, compared to their White counterparts. He also highlighted social determinants impacting the health of children with eczema, noting that factors like where a child lives and parental socioeconomic status can significantly affect the severity of their condition.

The Complexity of Diagnosing Cutaneous Lymphoma

The conversation shifted to the challenges surrounding the diagnosis of cutaneous lymphoma, a often-misunderstood condition. 'Diagnosing cutaneous lymphoma can be quite tricky,' Dr. Daveluy explained, noting its similarity to conditions like eczema and psoriasis.

He pointed out that an accurate diagnosis may require multiple biopsies, as initial tests often fail to reveal the lymphoma. Key indicators include atrophic appearance and distribution in sun-protected areas such as the buttocks and groin. Dr. Daveluy stressed the importance of correct diagnosis; missteps can lead to inappropriate treatments that exacerbate the condition.

Exciting Developments in Hidradenitis Suppurativa (HS) Treatment

When discussing hidradenitis suppurativa (HS), Dr. Daveluy expressed his optimism regarding innovative treatments on the horizon. 'We're witnessing a surge in biologics aimed at distinct immune pathways, expanding our understanding of the immune system,' he remarked.

He also introduced the promising new class of drugs known as nanobodies, which function similarly to biologics but have the advantage of penetrating tissues more effectively due to their smaller size. 'This could significantly improve treatment outcomes for HS patients,' he asserted.

Moreover, Dr. Daveluy pointed out the growing focus on surgical interventions alongside medication, noting, 'Many patients with HS require a combination of both to effectively manage their tunnels and persistent lesions.' He welcomed the recent increase in surgical studies, anticipating that these insights will shape future treatment strategies.

Final Thoughts

Dr. Daveluy's insights underscore a pivotal shift toward more inclusive and effective dermatological care. As research advances, the dermatology community may soon be better equipped to serve diverse populations, ensuring that all patients, regardless of their background, receive the high-quality care they deserve. Tune in to his full interview for more in-depth insights!